Artiva Biotherapeutics
ARTV----
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Artiva Biotherapeutics(ARTV) predict that the EBIT is -24.43 M (-10.19%), Miss estimate;the EPS is -0.95 (-14.46%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
TBA--
0.00B--
----
EBITMiss expectations
-0.02B10.19%
-0.02B4.37%
-0.00B5.82%
EPSMiss expectations
-0.9514.46%
-0.8654.22%
-0.085010.24%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf